Bill Texts: NJ A5101 | 2018-2019 | Regular Session

Bill Title: Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical manufacturers.

Spectrum: Partisan Bill (Democrat 2-0)

Status: (Introduced - Dead) 2019-03-05 - Introduced, Referred to Assembly Health and Senior Services Committee [A5101 Detail]

Bill Drafts

RevisionDateFormatSourceView
Introduced2019-03-05HTML/TextLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for New Jersey A5101

Supplemental Documents

TitleDescriptionDateFormatSourceView
No supplemental documents for New Jersey A5101 currently on file.

Social Comments on NJ A5101

feedback